Skip to content

Diabetes Lifestyle Intervention Study Slotervaarthospital

The effects of a behavior change lifestyle intervention program on physical activity and clinical parameters of diabetes in patients with insulin dependent type 2 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22216
Enrollment
74
Registered
2008-10-21
Start date
2005-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

physical activity insulin dependent type 2 diabetes behavior change

Interventions

The intervention program was based on the PACE (Physician-based Assessment and Counseling for Exercise) program
to stimulate exercise in participants on low profile by written information, short personal advise and telephone follow-up. The program consisted of 4 visits per year at the physiotherapist and a 15-

Sponsors

Diabetespoliclinic Department of internal medicine Slotervaarthospital Louwesweg 6 1006 BK Amsterdam The Netherlands Tel: +3120-5129333 Web: www.slz.nl
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. A clinical trial involving patients at the Dutch Slotervaart Hospital, who had type 2 diabetes and were using insulin. Subjects aged until 70 years and exercising less than 180 minutes per week, spread over at least three times per week, were included to the study.

Exclusion criteria

Exclusion criteria: Eligible persons were excluded if they met one of the following conditions: 1. Poor knowledge of the Dutch language 2. Life-expectancy of less than 5 years 3. Clinical manifest cardiovascular disease (hospitalization as a result of heart disease until 6 months before inclusion 4. Angina pectoris class ¡Ý II (NYHA) 5. Left heart-block or aorta-stenosis) 6. Pregnant women 7. Repeated hospitalization because of recurrent hypoglycaemia 8. Pre-terminal kidney-failure 9. Proliferative retinopathy 10. Usage of an insulin pump 11. Revalidation therapy 12. Psychiatric diseases 13. Chronic alcohol and/or drugs abuse 14. Decreased physical tolerance because of unrelated diabetic co-morbidity, like COPD or immune diseases.

Design outcomes

Primary

MeasureTime frame
Primary outcome measure was: - the change in physical activity measured by the Tecumseh/Minnesota scale.

Secondary

MeasureTime frame
Secondary outcome measures were: - differences in quality of life (W-BQ12 scale) - medication use - body composition - tension - laboratory markers of diabetes - macro and microvascular complications.

Contacts

Public ContactWilleke Wisse

Slotervaarthospital Department of internal medicine Diabetespoliclinic

willekewisse@xs4all.nl3120-5129333

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)